- Home
- MRK vs WFC Comparison
MRK vs WFC Comparison
Compare MRK & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | WFC |
|---|---|---|
| Founded | 2000 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 261.7B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRK | WFC |
|---|---|---|
| Price | $145.90 | $84.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 27 |
| Target Price | ★ $157.28 | $99.02 |
| AVG Volume (30 Days) | 5.8M | ★ 9.9M |
| Earning Date | 10-29-2026 | 10-13-2026 |
| Dividend Yield | 2.39% | ★ 2.44% |
| EPS Growth | 8.01 | ★ 16.57 |
| EPS | N/A | ★ 3.60 |
| Revenue | $65,011,000,000.00 | ★ $85,063,000,000.00 |
| Revenue This Year | $3.21 | $6.02 |
| Revenue Next Year | $4.42 | $4.74 |
| P/E Ratio | ★ N/A | $22.79 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $82.01 | $72.78 |
| 52 Week High | $157.00 | $97.76 |
Technical Indicators
Market Signals| Indicator | MRK | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 51.26 |
| Support Level | $144.04 | $83.38 |
| Resistance Level | $153.19 | $86.89 |
| Average True Range (ATR) | 3.64 | 1.72 |
| MACD | -0.64 | 0.14 |
| Stochastic Oscillator | 49.76 | 69.32 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About WFC Wells Fargo & Company
Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.